Sun Pharma Announces Top-Line Results from the Phase 2 Clinical Trials Evaluating SCD-044 for Moderate to Severe Psoriasis and Atopic Dermatitis by ananthi | Jun 3, 2025 | Press ReleasesRead More
Press Release Completion of Checkpoint Acquisition by ananthi | May 30, 2025 | Press ReleasesRead More
Sun Pharma reports Q4 and full year results for FY25 by ananthi | May 22, 2025 | Press ReleasesRead More
Sun Pharma Launches Corporate Brand Campaign in India by ananthi | May 6, 2025 | UncategorizedRead More
Sun Pharma and Moebius Medical Announce Dual Publications on MM-II’s Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage by ananthi | May 6, 2025 | UncategorizedRead More
Recent Comments